Ikarian Capital, LLC

SEC CIK: 0001778253
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

CHRS holding history

Coherus Oncology, Inc. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CHRS overview All 13F holders of CHRS Full Q2 2026 holdings

Shares (Q1 2024): 0; Sold out in Q1 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2023

Holdings of CHRS by Ikarian Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2024	0	$0	0.0%	−340,787−100.0%	Sold out	Holders
Q4 2023	340,787	$1.13M	0.3%	−525,000−60.6%	Reduced	Holders
Q3 2023	865,787	$3.24M	1.2%	+865,787	New	Holders